Palvella Therapeutics Statistics
Total Valuation
PVLA has a market cap or net worth of $229.74 million. The enterprise value is $157.09 million.
| Market Cap | 229.74M |
| Enterprise Value | 157.09M |
Important Dates
The next confirmed earnings date is Thursday, May 15, 2025, before market open.
| Earnings Date | May 15, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
PVLA has 11.02 million shares outstanding. The number of shares has increased by 24.08% in one year.
| Current Share Class | 11.02M |
| Shares Outstanding | 11.02M |
| Shares Change (YoY) | +24.08% |
| Shares Change (QoQ) | +92.52% |
| Owned by Insiders (%) | 18.00% |
| Owned by Institutions (%) | 19.70% |
| Float | 6.29M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 4.01 |
| P/TBV Ratio | 3.65 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.33, with a Debt / Equity ratio of 0.19.
| Current Ratio | 7.33 |
| Quick Ratio | 7.14 |
| Debt / Equity | 0.19 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -3.27 |
Financial Efficiency
Return on equity (ROE) is -59.37% and return on invested capital (ROIC) is -22.38%.
| Return on Equity (ROE) | -59.37% |
| Return on Assets (ROA) | -18.39% |
| Return on Invested Capital (ROIC) | -22.38% |
| Return on Capital Employed (ROCE) | -18.50% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.25M |
| Employee Count | 14 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 24.79 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 38.44 |
| Average Volume (20 Days) | 81,583 |
Short Selling Information
The latest short interest is 251,360, so 2.28% of the outstanding shares have been sold short.
| Short Interest | 251,360 |
| Short Previous Month | 182,844 |
| Short % of Shares Out | 2.28% |
| Short % of Float | 4.00% |
| Short Ratio (days to cover) | 0.40 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -14.10M |
| Pretax Income | n/a |
| Net Income | -17.43M |
| EBITDA | n/a |
| EBIT | -14.10M |
| Earnings Per Share (EPS) | -$7.83 |
Balance Sheet
The company has $83.60 million in cash and $11.94 million in debt, giving a net cash position of $71.66 million or $6.50 per share.
| Cash & Cash Equivalents | 83.60M |
| Total Debt | 11.94M |
| Net Cash | 71.66M |
| Net Cash Per Share | $6.50 |
| Equity (Book Value) | 62.61M |
| Book Value Per Share | 5.69 |
| Working Capital | 76.20M |
Cash Flow
| Operating Cash Flow | -10.84M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
PVLA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -24.08% |
| Shareholder Yield | -24.08% |
| Earnings Yield | -7.62% |
| FCF Yield | n/a |
Analyst Forecast
The average price target for PVLA is $44.43, which is 113.09% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $44.43 |
| Price Target Difference | 113.09% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |